Figure 3From: Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite FTIR Spetra of free 4-amino salicylic acid (A) and 4ASA-nanocomposite (B). Back to article page